Elizabeth Wille

2.4k total citations
22 papers, 2.0k citations indexed

About

Elizabeth Wille is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Elizabeth Wille has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Neurology and 8 papers in Physiology. Recurrent topics in Elizabeth Wille's work include Mitochondrial Function and Pathology (7 papers), Amyotrophic Lateral Sclerosis Research (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Elizabeth Wille is often cited by papers focused on Mitochondrial Function and Pathology (7 papers), Amyotrophic Lateral Sclerosis Research (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Elizabeth Wille collaborates with scholars based in United States, Germany and United Kingdom. Elizabeth Wille's co-authors include Noel Y. Calingasan, M. Flint Beal, M. Flint Beal, Magali Dumont, Lichuan Yang, Mahmoud Kiaei, Michael T. Lin, Cliona Stack, Michael B. Sporn and Daniel Ho and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Elizabeth Wille

21 papers receiving 1.9k citations

Peers

Countries citing papers authored by Elizabeth Wille

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Wille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Wille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Wille more than expected).

Fields of papers citing papers by Elizabeth Wille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Wille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Wille. The network helps show where Elizabeth Wille may publish in the future.

Co-authorship network of co-authors of Elizabeth Wille

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Wille. A scholar is included among the top collaborators of Elizabeth Wille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Wille. Elizabeth Wille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease 2011 ·Neuroscience Letters ·Magali Dumont, Cliona Stack, (unknown), Noel Y. Calingasan, Elizabeth Wille, M. Flint Beal	20
2	Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis 2011 ·Free Radical Biology and Medicine ·(unknown), Noel Y. Calingasan, Elizabeth Wille, (unknown), Susanne Petri, Maria Damiano, Karen T. Liby, Renee Risingsong, Michael B. Sporn, M. Flint Beal, Mahmoud Kiaei	171
3	Mitochondrial Permeability Transition Pore Component Cyclophilin D Distinguishes Nigrostriatal Dopaminergic Death Paradigms in the MPTP Mouse Model of Parkinson's Disease 2011 ·Antioxidants and Redox Signaling ·Bobby Thomas, Rebecca Banerjee, Natalia N. Starkova, (unknown), Noel Y. Calingasan, Lichuan Yang, Elizabeth Wille, Beverly Lorenzo, Daniel Ho, M. Flint Beal, Anatoly A. Starkov	47
4	Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease 2010 ·Free Radical Biology and Medicine ·Cliona Stack, Daniel Ho, Elizabeth Wille, Noel Y. Calingasan, Charlotte R. Williams, Karen T. Liby, Michael B. Sporn, Magali Dumont, M. Flint Beal	143
5	Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease 2010 ·Experimental Neurology ·Daniel Ho, Noel Y. Calingasan, Elizabeth Wille, Magali Dumont, M. Flint Beal	114
6	Triterpenoid CDDO‐methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease 2009 ·Journal of Neurochemistry ·Magali Dumont, Elizabeth Wille, Noel Y. Calingasan, Davide Tampellini, Charlotte R. Williams, Gunnar K. Gouras, Karen T. Liby, Michael B. Sporn, M. Flint Beal, Michael T. Lin	95
7	N-iminoethyl-l-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition 2009 ·Neurochemistry International ·Magali Dumont, Elizabeth Wille, Noel Y. Calingasan, Carl Nathan, M. Flint Beal, Michael T. Lin	11
8	Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins 2009 ·Neurobiology of Disease ·Lichuan Yang, Qingli Shi, Daniel Ho, Anatoly A. Starkov, Elizabeth Wille, Hui Xu, (unknown), (unknown), Cliona Stack, Noel Y. Calingasan, Gary E. Gibson, M. Flint Beal	22
9	Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis 2009 ·Experimental Neurology ·(unknown), Susanne Petri, Noel Y. Calingasan, Elizabeth Wille, Peter Schäfer, Charles A. Stewart, Kenneth Hensley, M. Flint Beal, Mahmoud Kiaei	62
10	Combination therapy with Coenzyme Q₁₀ and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases 2009 ·Journal of Neurochemistry ·Lichuan Yang, Noel Y. Calingasan, Elizabeth Wille, Kerry Cormier, Karen Smith, Robert J. Ferrante, M. Flint Beal	188
11	Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription 2009 ·PLoS ONE ·Lichuan Yang, Noel Y. Calingasan, Bobby Thomas, Rajnish Kumar Chaturvedi, Mahmoud Kiaei, Elizabeth Wille, Karen T. Liby, Charlotte R. Williams, Darlene B. Royce, Renee Risingsong, Erik S. Musiek, Jason D. Morrow, Michael B. Sporn, M. Flint Beal	144
12	Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease 2009 ·The FASEB Journal ·Magali Dumont, Elizabeth Wille, Cliona Stack, Noel Y. Calingasan, M. Flint Beal, Michael T. Lin	188
13	Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases 2008 ·Neuroscience ·Noel Y. Calingasan, Daniel Ho, Elizabeth Wille, Marcello Campagna, Jia Ruan, Magali Dumont, Le Yang, Qingli Shi, Gary E. Gibson, M. Flint Beal	60
14	Klinische Bedeutung der Immunglobulin-M-Antikörperfraktion gegen das Hepatitis-B-core-Antigen (anti-HBc-IgM) 2008 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), Elizabeth Wille, R. Müller	0
15	Therapeutic effects of coenzyme Q₁₀ (CoQ₁₀) and reduced CoQ₁₀ in the MPTP model of Parkinsonism 2007 ·Journal of Neurochemistry ·Carine Cléren, Lichuan Yang, Beverly Lorenzo, Noel Y. Calingasan, (unknown), Anthony Sireci, Elizabeth Wille, M. Flint Beal	121
16	The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis 2007 ·Journal of Neurochemistry ·Susanne Petri, Noel Y. Calingasan, Osama Alsaied, Elizabeth Wille, Mahmoud Kiaei, Jonathan E. Friedman, Oxana V. Baranova, Juan C. Chávez, M. Flint Beal	48
17	Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis 2007 ·Experimental Neurology ·Mahmoud Kiaei, (unknown), Noel Y. Calingasan, Elizabeth Wille, (unknown), Beate Heissig, Shahin Rafii, Stefan Lorenzl, (unknown)	95
18	Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice 2006 ·Journal of the Neurological Sciences ·Susanne Petri, Mahmoud Kiaei, Elizabeth Wille, Noel Y. Calingasan, M. Flint Beal	34
19	Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis 2006 ·Journal of Neurochemistry ·Susanne Petri, Mahmoud Kiaei, Maria Damiano, (unknown), Elizabeth Wille, Giovanni Manfredi, Noel Y. Calingasan, Hazel H. Szeto, M. Flint Beal	138
20	Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis 2006 ·Aktuelle Neurologie ·Susanne Petri, Mahmoud Kiaei, Maria Damiano, (unknown), Elizabeth Wille, Giovanni Manfredi, Noel Y. Calingasan, Hazel H. Szeto, M. F. Beal	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact